Execs On The Move: Month(xxx) 2024
Listen to this article
Executive Summary
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Candid conversations with C-suite leaders.
More from In Vivo
• By
Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.
• By
Launching In Vivo’s oncology therapeutic review series, this first instalment provides a data-led primer on the global cancer landscape. Future instalments will explore market dynamics, pipeline evolution and the innovations set to define oncology therapeutics through 2032.